CNS Pharmaceuticals, Inc.
CNSP
$1.13
$0.00490.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.46M | 6.97M | 1.49M | 815.20K | 548.70K |
| Total Receivables | 882.50K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.29M | 388.00K | 637.10K | 786.10K | 839.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.60K | 26.90K | 16.80K | -- | 202.90K |
| Total Current Assets | 8.66M | 7.39M | 2.15M | 1.60M | 1.59M |
|
|
|||||
| Total Current Assets | 8.66M | 7.39M | 2.15M | 1.60M | 1.59M |
| Net Property, Plant & Equipment | 6.00K | 2.80K | 3.60K | 4.30K | 4.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.40K | 18.40K | 320.30K | 55.30K | 104.80K |
| Total Assets | 8.70M | 7.41M | 2.47M | 1.66M | 1.70M |
|
|
|||||
| Total Accounts Payable | 2.20M | 4.03M | 6.64M | 5.88M | 5.83M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 326.10K | 31.20K | 123.20K | 213.10K | 300.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.52M | 4.06M | 6.76M | 6.09M | 6.13M |
|
|
|||||
| Total Current Liabilities | 2.52M | 4.06M | 6.76M | 6.09M | 6.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 326.10K | 31.20K | 123.20K | 213.10K | 300.80K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.52M | 4.06M | 6.76M | 6.09M | 6.13M |
|
|
|||||
| Common Stock & APIC | 90.60M | 84.60M | 71.35M | 68.68M | 65.13M |
| Retained Earnings | -84.42M | -81.25M | -75.64M | -73.11M | -69.57M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.18M | 3.35M | -4.29M | -4.43M | -4.43M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.18M | 3.35M | -4.29M | -4.43M | -4.43M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.18M | 3.35M | -4.29M | -4.43M | -4.43M |
|
|
|||||